Home/Filings/4/0001415889-25-002267
4//SEC Filing

Hasija Amit 4

Accession 0001415889-25-002267

CIK 0001408443other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:15 PM ET

Size

8.2 KB

Accession

0001415889-25-002267

Insider Transaction Report

Form 4
Period: 2025-01-27
Hasija Amit
CFO & EVP of Corp. Development
Transactions
  • Award

    Restricted Stock Unit

    2025-01-27+80,40080,400 total
    Common Shares (80,400 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-01-27+120,600120,600 total
    Exercise: $2.02Exp: 2035-01-27Common Shares (120,600 underlying)
Footnotes (3)
  • [F1]One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F2]Each restricted stock unit represents a contingent right to receive one common share.
  • [F3]One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Milestone Pharmaceuticals Inc.

CIK 0001408443

Entity typeother

Related Parties

1
  • filerCIK 0001787700

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:15 PM ET
Size
8.2 KB